EUVIMEDEUVIMED entdecken
Crossref

Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery

Roxane Varengue, Matthieu Delion, Emilie De Carli, Luc Le Fournier, Julien Durigneux, Mickael Dinomais, Patrick Van Bogaert

Archives de Pédiatrie · 2024

DOI: 10.1016/j.arcped.2023.10.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives de Pédiatrie, 2024. Verfasst von Roxane Varengue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropediatrics and Pediatric Neurosurgery, Angers University Hospital, 4 rue Larrey, 49100 Angers, France. Electronic address: roxane.…. Hauptthemen laut MEDLINE: Fluoxetine, Mutism, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cerebellar mutism syndrome (CMS) occurs in 8-29 % of children undergoing posterior fossa tumor surgery. Its main symptoms are mutism and emotional lability. Although it is always transient, recovery time can be lengthy with long-term cognitive sequelae. There is no approved drug treatment for CMS, but some drugs are used in everyday medical practice. One of these is fluoxetine, which has been used for many years in our institution. The main objective of this study was to establish the safety profile of fluoxetine in this condition. MATERIALS AND METHODS: The records of patients admitted to the pediatric intensive care unit after brain surgery at Angers University Hospital from 2010 to 2020 were reviewed. Children aged 2 years and older who underwent a posterior fossa tumor surgery and were diagnosed with CMS were included. Data on patient characteristics, prescription of fluoxetine treatment, side effects if any, and complete mutism duration were collected. RESULTS: Among 246 patients admitted to the pediatric intensive care unit for brain surgery during the study period, 23 had CMS and eight were prescribed fluoxetine. No serious adverse event related to fluoxetine was reported. Complete mutism duration did not differ significantly between the fluoxetine group and the non-fluoxetine group(p = 0.22). However, the treatment was initiated after recovery from complete mutism in half of the treated patients. CONCLUSION: This study suggests a positive safety profile of fluoxetine used in postoperative CMS. It does not answer the question of whether the treatment is effective for this indication. A randomized controlled trial based on a syndrome severity scale should be conducted to provide a more reliable assessment of the efficacy and safety of fluoxetine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineMutismPostoperative ComplicationsHumansMaleChildFemaleChild, PreschoolRetrospective StudiesSelective Serotonin Reuptake InhibitorsInfratentorial NeoplasmsCerebellar DiseasesAdolescentSyndromeNeurosurgical Procedures

Stichwörter der Autor:innen

Cerebellar mutism syndromeFluoxetineNeurosurgeryPosterior fossa tumor

Substanzen

FluoxetineSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Neuropediatrics and Pediatric Neurosurgery, Angers University Hospital, 4 rue Larrey, 49100 Angers, France. Electronic address: roxane.varengue@chu-angers.fr.
  • Department of Neuropediatrics and Pediatric Neurosurgery, Angers University Hospital, 4 rue Larrey, 49100 Angers, France.
  • Pediatric oncology department, Angers University Hospital, 4 rue Larrey, 49100 Angers, France.
  • Department of Neuropediatrics and Pediatric Neurosurgery, Angers University Hospital, 4 rue Larrey, 49100 Angers, France; Pediatric Physical Medicine and Rehabilitation Department, Les Capucins, 11 boulevard Jean Sauvag…
  • Pediatric Physical Medicine and Rehabilitation Department, Les Capucins, 11 boulevard Jean Sauvage, 49100 Angers, France; Laboratoire Angevin de recherche en ingénierie des systèmes (LARIS) EA7315, University of Angers,…
  • Department of Neuropediatrics and Pediatric Neurosurgery, Angers University Hospital, 4 rue Larrey, 49100 Angers, France; Laboratoire Angevin de recherche en ingénierie des systèmes (LARIS) EA7315, University of Angers,…

Zitieren

APA

Varengue, R., Delion, M., De Carli, E., Fournier, L. L., Durigneux, J., Dinomais, M., & Van Bogaert, P. (2024). Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Archives de Pédiatrie. https://doi.org/10.1016/j.arcped.2023.10.010

Vancouver

Varengue R, Delion M, De Carli E, Fournier LL, Durigneux J, Dinomais M, et al. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Archives de Pédiatrie. 2024. doi:10.1016/j.arcped.2023.10.010

BibTeX
@article{Varengue2024,
  author = {Varengue, Roxane and Delion, Matthieu and De Carli, Emilie and Fournier, Luc Le and Durigneux, Julien and Dinomais, Mickael and Van Bogaert, Patrick},
  title = {Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery},
  journal = {Archives de Pédiatrie},
  year = {2024},
  doi = {10.1016/j.arcped.2023.10.010}
}
Kostenlos starten →